NCT06435871Completed
Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors
Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors: Understanding Cultural Nuances in Survivorship Decision Making
Source: ClinicalTrials.gov · Last updated 15 Sept 2026
Brief summary (registry, in English)
Prostate cancer is a significant concern for Latiné men, with over 17,000 new cases annually. Decision-making for treatment is complex, especially due to barriers like low health literacy and cultural factors. Research on survivorship and post-treatment issues like erectile dysfunction is lacking. To improve care, a study will engage 288 participants across various medical facilities, including 100 at Cleveland Clinic. Thirty subjects will participate in focus groups representing Spanish-speaking Latiné, bilingual Latiné, and English-speaking non-Latiné individuals to understand their perspectives and enhance communication. This aims to develop tailored resources, like Spanish-language educational videos, addressing language and cultural needs for informed decision-making.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 55 (actual)
- First submitted
- 24 May 2024
- Start date
- 8 Oct 2024
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- Case Comprehensive Cancer Center
- Diseases
- Prostate cancer
- NCT number
- NCT06435871
What you commit to
- Study type: Interventional
- Participants enrolled: 55
- From 8 Oct 2024 to the primary completion date, 1 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who had brachytherapy and/or radiation treatment as their initial treatment
- Patients who underwent current non-standard prior treatment options for localized prostate cancer including cryotherapy and high intensity focused ultrasound (HIFU)
Other illness
- Patients with disease progression at time study recruitment who are requiring other treatments (ADT, chemotherapy, immunotherapy)
Other
- Patient whose primary language is not English or Spanish
Who the study is looking for
- Adults \>18 years
- Diagnosis of Localized Prostate Cancer
- Underwent radical prostatectomy by their urological surgeon
- Subjects must have the ability to understand and the willingness to sign a written informed consent document
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.